Drying of Opzelura® (Ruxolitinib) Cream 1.5%: Implications for Clinical and Real-World Use. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 8, n. 6, p. s454, 2024. DOI: 10.25251/skin.8.supp.454. Disponível em: https://skin.dermsquared.com/skin/article/view/3063. Acesso em: 26 may. 2026.